| Spirig HealthCare AG - Levetiracetam Spirig HC 100 mg/ml, Lösung zum Einnehmen | | 69095 | | 01 | | Levetiracetam Spirig HC 100 mg/ml | | Lösung zum Einnehmen | | N03AX14 | | Levetiracetam | | 14.12.2023 | | |
| | Composition | | levetiracetamum 100 mg, natrii citras dihydricus, acidum citricum, E 218 2.5 mg, glycerolum, acesulfamum kalicum, maltitolum liquidum 300 mg, aromatica (Himbeere) cum alcohol benzylicus 0.0016 mg et propylenglycolum, aqua purificata, ad solutionem pro 1 ml corresp. natrium 0.99 mg. | | Packungsbestandteile | | Solution (orale) | | | | | | | | Principe actif | Concentr. |
|---|
| Levetiracetame | 100 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Levetiracetame | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acesulfamum Kalicum | | | | Acide Citrique | | | | Aqua Purificata | | | | Aromatica (Himbeere) cum Alcohol Benzylicus | 0.0016 mg/ml | | | E 218 | 2.5 mg/ml | conserv. | | Glycerol | | | | Maltitolum Liquidum | 300 mg/ml | | | Natrii Citras Dihydricus | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 300 ml | 44.50 | 64.95 | B | LS | Non |
|
|
